Annual Lung SPORE Workshop (Abstract Submission): Submission #67

Submission information
Submission Number: 67
Submission ID: 110626
Submission UUID: f2f38073-6cf0-4df5-9645-0a236130106c

Created: Mon, 03/11/2024 - 13:59
Completed: Mon, 03/11/2024 - 14:47
Changed: Mon, 05/06/2024 - 10:59

Remote IP address: 10.208.28.228
Submitted by: Anonymous
Language: English

Is draft: No





Abstract Submission
-------------------






First Name: Mustafa









Last Name: Al-Dulaimi









Email: mustafa_al-dulaimi@dfci.harvard.edu









Phone: 12087180181









Affiliation - Presenter: Dana-Farber Cancer Institute









Abstract Title:
CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC)










First Author
------------






First Author First Name: Mustafa









First Author Last Name: Al-Dulaimi









Affiliation: DFCI













Additional Authors
------------------






List of Additional Authors:
- First Name: Antja-Voy
  Last Name: Hartley
  Affiliation: DFCI
- First Name: Simon
  Last Name: Baldacci
  Affiliation: DFCI
- First Name: Matthew 
  Last Name: Booker
  Affiliation: DFCI
- First Name:  Nathanael 
  Last Name: Gray
  Affiliation: Stanford Cancer Institute
- First Name: Michael
  Last Name: Tolsturokov
  Affiliation: DFCI
- First Name: Pasi
  Last Name: Janne
  Affiliation: DFCI














Select a Session Topic: Session 6: Cancer Biology









Upload Abstract: https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/110626/ABRCMS%202023%20Abstract_MA%209-7-23.docx









Special Characters Included?: No













Abstract Review Status: Approved to be a Poster Presenter









Poster Uploaded: {Empty}









Poster Submission
-----------------






Upload Poster: {Empty}